|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Purchase of ordinary shares through the Company's Dividend
Re-Investment Plan following the 2025 final dividend payment on 27
May 2026.
|
|
Date of Transaction
|
2026 - 05 - 27
|
|
Place of Transaction
|
London Stock Exchange (XLON)
|
|
Name
(Position)
|
Director / PDMR
|
Price
|
Volume
|
Aggregated information
|
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
11.38002
|
6,259.14583
|
N/A Single Transaction
|
|
John Rogers
(Chief Financial Officer)
|
Director
|
11.38002
|
61.89914
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
11.38002
|
1190.0452
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
11.38002
|
153.58792
|
N/A Single Transaction
|
|
Scott Schaffner
(President, Sports Medicine)
|
PDMR
|
11.38002
|
2148.33828
|
N/A Single Transaction
|
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
June 03, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|